| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Arunkumar Krishnan, Ruhee A Patel, Yousaf Bashir Hadi, Diptasree Mukherjee, Sarah Shabih, Shyam Thakkar, Shailendra Singh, Tinsay A Woreta and Saleh A Alqahtani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arunkumar Krishnan, MBBS, Doctor, Doctor, Research Fellow, Research Scientist, Section of Gastroenterology & Hepatology, West Virginia University School of Medicine, PO Box 9161, 5th Floor HSC, Room 5500
, Morgantown, WV 26505, United States. dr.arunkumar.krishnan@gmail.com |
| Key Words |
Autoimmune hepatitis; SARS-CoV-2; COVID-19; Mortality; Outcomes; Liver disease; Severe |
| Core Tip |
Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver of unknown etiology. Patients with AIH may be at increased risk of severe illness from coronavirus disease 2019 (COVID-19) and have poor outcomes due to underlying chronic liver disease (CLD) and ongoing pre-existing immunosuppression therapies. Patients with AIH are associated with increased hospitalization risk, severe disease, and all-cause mortality compared to patients without pre-existing CLDs from the diagnosis of COVID-19. Patients with AIH had a lower risk of several outcomes, including hospitalization, a necessity for critical care, and acute kidney injury, compared to patients with pre-existing CLDs other than AIH. |
| Publish Date |
2023-01-16 06:02 |
| Citation |
Krishnan A, Patel RA, Hadi YB, Mukherjee D, Shabih S, Thakkar S, Singh S, Woreta TA, Alqahtani SA. Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study. World J Hepatol 2023; 15(1): 68-78 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i1/68.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i1.68 |
